About Aptamer Sciences
Aptamer Sciences is a company based in Pohang-si (South Korea) founded in 2011. The company has 55 employees as of December 31, 2024. Aptamer Sciences operates in a competitive market with competitors including Aptamer Group, Base Pair Biotechnologies, Femtogenix, Apta Biotech and Aptus Biotech, among others.
- Headquarter Pohang-si, South Korea
- Employees 55 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aptamer Sciences, Inc.
-
Annual Revenue
$732.24 K (USD)345.26as on Dec 31, 2024
-
Net Profit
-$5.9 M (USD)36.02as on Dec 31, 2024
-
EBITDA
-$4.18 M (USD)47.04as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
55
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Aptamer Sciences
Aptamer Sciences is a publicly listed company on the KRX with ticker symbol 291650 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Aptamer Sciences
Detailed funding history for Aptamer Sciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aptamer Sciences
Investment portfolio details for Aptamer Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aptamer Sciences
Detailed financials for Aptamer Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aptamer Sciences Comparisons
Peer comparison for Aptamer Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aptamer Sciences
Aptamer Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aptamer Group, Base Pair Biotechnologies, Femtogenix, Apta Biotech and Aptus Biotech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Manufacturer of DNA and RNA nucleic acid aptamers for use in research & development
|
|
| Locked | Locked | Locked |
Services for custom aptamer development
|
|
| Locked | Locked | Locked |
DNA-interactive payload molecules for ADCs are developed by Femtogenix.
|
|
| Locked | Locked | Locked |
Aptamers are developed and provided via SELEX platform technology.
|
|
| Locked | Locked | Locked |
Aptamer-based biotechnological applications are developed for diverse uses.
|
Detailed competitors of Aptamer Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aptamer Sciences
Complete news archive for Aptamer Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aptamer Sciences
Aptamer Sciences was founded in 2011.
Aptamer Sciences is headquartered in Pohang-si, South Korea. It is registered at Pohang-si, North Gyeongsang Province, South Korea.
As of Dec 31, 2024, the latest employee count at Aptamer Sciences is 55.
Annual revenue of Aptamer Sciences is $732.24K as on Dec 31, 2024.
Aptamer Sciences was founded in 2011 as a biotechnology firm specializing in aptamer-based solutions. Technologies for protein analysis are commercialized through a proprietary platform, supported by an association with POSTECH. Broad access to SELEX intellectual property is held among four companies, enabling research and development of aptamers. Emphasis is placed on aptamers that target cellular proteins for diagnostic and analytical applications.
Aptamer Sciences's top competitors include Aptamer Group, Base Pair Biotechnologies and Apta Biotech.
Yes, Aptamer Sciences is publicly traded on KRX under the ticker symbol 291650.
The ticker symbol of Aptamer Sciences is 291650 on KRX.